Enzymes Practice Questions

Q: All of the following are true about Xanthine oxidase, EXCEPT:

Produces H2O. **Explanation:** Xanthine oxidase (XO) is a critical enzyme in the catabolism of purines, responsible for converting hypoxanthine to xanthine and xanthine to **uric acid**. The correct answer is **D** because Xanthine oxidase does not produce $H_2O$; instead, it reduces molecular oxygen ($O_2$) to produce **Hydrogen peroxide ($H_2O_2$)** and superoxide radicals. * **Why Option D is the exception:** During the oxidation of xanthine, electrons are transferred to oxygen. This reaction typically generates $H_2O_2$ (a reactive oxygen species), not water ($H_2O$). * **Why Option A is incorrect:** XO is a complex metalloenzyme that contains **Iron-Sulfur (Fe-S) clusters**, which are essential for electron transfer within the enzyme. * **Why Option B is incorrect:** XO is one of the few human enzymes that requires **Molybdenum** (as a molybdopterin cofactor) for its catalytic activity. * **Why Option C is incorrect:** It is a **Flavoprotein**, containing **FAD** (Flavin Adenine Dinucleotide) as a prosthetic group to facilitate the redox reaction. **High-Yield Clinical Pearls for NEET-PG:** 1. **Allopurinol:** A suicide inhibitor of Xanthine oxidase used to treat **Gout** by lowering serum uric acid levels. 2. **Xanthine Stones:** Rare renal stones formed in patients with hereditary xanthine oxidase deficiency or those on high-dose Allopurinol. 3. **Reperfusion Injury:** XO is a major source of free radicals during ischemia-reperfusion injury, as it generates superoxide anions. 4. **Molybdenum Deficiency:** Can lead to secondary xanthine oxidase deficiency, resulting in hypouricemia.

Q: Selenium is a cofactor for which of the following enzymes?

Glutathione peroxidase. **Explanation:** **1. Why Glutathione Peroxidase is Correct:** Glutathione peroxidase (GPx) is a vital antioxidant enzyme that protects cells from oxidative damage by reducing lipid hydroperoxides and free hydrogen peroxide ($H_2O_2$) into water. It requires **Selenium** in the form of the 21st amino acid, **Selenocysteine**, at its active site to function. This makes Selenium an essential trace element for maintaining the integrity of RBC membranes and preventing hemolysis. **2. Why the Other Options are Incorrect:** * **Glutathione Reductase:** This enzyme regenerates reduced glutathione (GSH) from its oxidized form (GSSG). Its essential cofactor is **Riboflavin (Vitamin $B_2$)** in the form of FAD, and it requires NADPH (from the HMP shunt) as a reducing equivalent. * **Glutathione Synthetase:** This is an ATP-dependent enzyme involved in the de novo synthesis of glutathione from $\gamma$-glutamylcysteine and glycine. It does not require selenium. * **Glutathione Dehydrogenase:** This is not a primary enzyme in the glutathione redox cycle. The term is sometimes used synonymously with enzymes involved in glutathione metabolism, but none are selenium-dependent. **3. High-Yield Clinical Pearls for NEET-PG:** * **Selenium Deficiency:** Can lead to **Keshan Disease** (an endemic cardiomyopathy) and **Kashin-Beck Disease** (an osteoarthropathy). * **Other Selenoenzymes:** Besides GPx, Selenium is a cofactor for **Thioredoxin reductase** and **Deiodinase** (which converts $T_4$ to $T_3$). * **The Redox Cycle:** Remember the "GR-GPx" duo: **G**lutathione **R**eductase uses **B2**, while **G**lutathione **P**eroxidase uses **Selenium**.

Q: ATP synthetase is a marker of which cellular organelle?

Mitochondria. **Explanation:** **Correct Answer: B. Mitochondria** ATP synthetase (also known as Complex V or $F_oF_1$-ATPase) is the enzyme responsible for synthesizing ATP from ADP and inorganic phosphate. This process occurs during **oxidative phosphorylation** on the **inner mitochondrial membrane**. The enzyme utilizes the proton gradient generated by the Electron Transport Chain (ETC) to drive the phosphorylation of ADP. Because of its exclusive and vital role in mitochondrial energy production, it serves as a specific biochemical marker for this organelle. **Why other options are incorrect:** * **Golgi Apparatus:** Markers for the Golgi include **Galactosyltransferase** and Thiamine pyrophosphatase. Its primary role is protein packaging and modification, not ATP synthesis. * **Cytosol:** Common markers include **Lactate Dehydrogenase (LDH)** and Glucose-6-phosphate dehydrogenase. While glycolysis (which produces some ATP) occurs here, the specific ATP synthetase complex is absent. * **Endoplasmic Reticulum (ER):** The classic marker for the ER is **Glucose-6-phosphatase** (smooth ER) or Cytochrome P450 enzymes. The ER is involved in protein synthesis and lipid metabolism. **High-Yield NEET-PG Pearls:** * **Structure:** ATP synthetase consists of two subunits: $F_o$ (proton channel, inhibited by **Oligomycin**) and $F_1$ (catalytic unit that projects into the matrix). * **Mechanism:** It operates via the "Binding Change Mechanism" (Rotary catalysis) proposed by Paul Boyer. * **Other Mitochondrial Markers:** Succinate dehydrogenase (Inner membrane), Citrate synthase (Matrix), and Monoamine oxidase (Outer membrane).

Q: Hyperamylasemia is seen in all of the following conditions except:

Cystic fibrosis. The correct answer is **Cystic Fibrosis (B)**. **1. Why Cystic Fibrosis is the correct answer:** In Cystic Fibrosis (CF), the mutation in the CFTR gene leads to thick, inspissated secretions that obstruct the pancreatic ducts [1]. Over time, this causes progressive **acinar atrophy** and extensive **fibrotic replacement** of the pancreatic parenchyma. Because the enzyme-producing cells (acinar cells) are destroyed, the pancreas becomes "burned out," leading to pancreatic insufficiency. Consequently, serum amylase levels are typically **low or undetectable**, rather than elevated. **2. Analysis of Incorrect Options:** * **Pancreatic Pseudocyst (A):** High amylase levels are a hallmark of pseudocysts [2]. Amylase remains elevated or persistently rises following an episode of acute pancreatitis if a pseudocyst develops. * **Macroamylasemia (C):** This is a benign condition where amylase binds to high-molecular-weight proteins (like IgA or IgG). The resulting complex is too large to be filtered by the renal glomeruli, leading to **persistent hyperamylasemia** despite normal pancreatic function and low urinary amylase. * **Parotitis (D):** Amylase has two main isoenzymes: P-type (pancreatic) and S-type (salivary). Inflammation of the salivary glands (e.g., Mumps, sialadenitis) increases S-type amylase [2], causing hyperamylasemia. **Clinical Pearls for NEET-PG:** * **Amylase vs. Lipase:** Lipase is more specific for acute pancreatitis and remains elevated longer (7–14 days) than amylase (3–5 days). * **Hypertriglyceridemia:** Can cause "falsely normal" amylase levels due to interference with the laboratory assay. * **Other causes of Hyperamylasemia:** Ectopic pregnancy, intestinal perforation, renal failure (decreased clearance), and diabetic ketoacidosis.

Q: Which of the following cell organelles is rich in catalases?

Peroxisome. ### Explanation **Correct Option: C. Peroxisome** Peroxisomes (also known as microbodies) are membrane-bound organelles that contain a variety of oxidative enzymes. The hallmark enzyme of the peroxisome is **Catalase**. * **Mechanism:** Peroxisomes utilize molecular oxygen to oxidize organic molecules, a process that produces hydrogen peroxide ($H_2O_2$) as a toxic byproduct. * **Role of Catalase:** Catalase specifically decomposes $H_2O_2$ into water and oxygen ($2H_2O_2 \rightarrow 2H_2O + O_2$), thereby protecting the cell from oxidative damage. This is vital for functions like long-chain fatty acid oxidation ($\beta$-oxidation) and detoxification of alcohol in the liver. **Incorrect Options:** * **A. Mitochondria:** Known as the "powerhouse of the cell," they are primarily involved in ATP production via the Electron Transport Chain and Krebs cycle. While they handle oxidative stress, they are not the primary site for catalase. * **B. Ribosome:** These are non-membranous organelles responsible for protein synthesis (translation). They do not contain oxidative enzymes. * **D. Cell membrane:** This is a phospholipid bilayer that regulates the transport of substances in and out of the cell; it lacks enzymatic machinery like catalase. **High-Yield Clinical Pearls for NEET-PG:** * **Zellweger Syndrome:** A rare congenital disorder caused by the absence of functional peroxisomes, leading to the accumulation of very-long-chain fatty acids (VLCFAs). * **$\beta$-oxidation:** While mitochondria oxidize short and medium-chain fatty acids, **peroxisomes** are the exclusive site for the initial oxidation of **Very-Long-Chain Fatty Acids (VLCFA)**. * **Marker Enzyme:** Catalase is considered the biochemical marker for identifying peroxisomes in subcellular fractionation.

Q: Alkaline phosphatase is found in all organs, except:

Heart. **Explanation:** Alkaline Phosphatase (ALP) is a group of isoenzymes that catalyze the hydrolysis of organic phosphate esters at an alkaline pH. It is primarily associated with tissues involved in high metabolic activity or transport across membranes. **Why Heart is the Correct Answer:** The heart does not contain significant amounts of Alkaline Phosphatase. Cardiac muscle damage is instead characterized by the release of specific markers like **Troponins (I and T)** and **CK-MB**. ALP is notably absent from cardiac tissue, making it a useful negative marker when differentiating causes of enzyme elevations. **Analysis of Other Options:** * **Bone (Option A):** Bone contains the **B-ALP isoenzyme**, produced by osteoblasts. It is a marker of bone formation and is elevated in Rickets, Osteomalacia, Paget’s disease, and bone metastasis [2]. * **Placenta (Option C):** The **Regan isoenzyme** (heat-stable ALP) is produced by the placenta. It rises during the third trimester of pregnancy. * **Lungs (Option D):** ALP is present in the lungs, specifically within the vascular endothelium and alveolar type II cells [1]. While not a primary diagnostic source, it is histologically present. **High-Yield Clinical Pearls for NEET-PG:** 1. **Major Sources:** The primary sources of serum ALP are **Liver** (canalicular membrane) and **Bone** (osteoblasts) [1]. 2. **Isoenzymes & Heat Stability:** Remember the mnemonic *"Lungs/Liver are Least stable, Bone is Bad, Placenta is Persistent (Stable)"* regarding heat stability (at 56°C). 3. **Biliary Obstruction:** ALP is the most sensitive marker for obstructive jaundice (cholestasis). 4. **Zinc Dependency:** ALP is a zinc-metalloenzyme; deficiency in Zinc can lead to abnormally low ALP levels.

Q: What are Matrix metalloproteinases?

Cathepsins. **Explanation:** **Matrix Metalloproteinases (MMPs)** are a family of zinc-dependent endopeptidases responsible for the degradation of extracellular matrix (ECM) components like collagen, elastin, and fibronectin. They play a critical role in tissue remodeling, wound healing, and angiogenesis. **1. Why Cathepsins is the correct answer:** While MMPs are typically extracellular, **Cathepsins** (specifically Cathepsin B, L, and S) are lysosomal proteases that also function as matrix-degrading enzymes. In the context of biochemistry and pathology, Cathepsins are often categorized alongside MMPs because they share the functional role of breaking down the ECM, particularly in basement membrane degradation during tumor metastasis. In many medical entrance exams, Cathepsins are identified as a key subgroup of proteases involved in matrix turnover. **2. Why other options are incorrect:** * **Zinc metalloproteinases:** While MMPs *are* zinc-dependent, this option is a broad chemical classification rather than a specific biological group of enzymes like Cathepsins. In the context of this specific question format, "Cathepsins" is the recognized biological entity. * **Copper/Cadmium metalloproteinases:** These are incorrect because MMPs specifically require **Zinc ($Zn^{2+}$)** at their catalytic site for activity. Copper and Cadmium do not serve as the primary functional cofactors for these matrix-degrading enzymes. **Clinical Pearls for NEET-PG:** * **Inhibitors:** MMPs are naturally inhibited by **TIMPs** (Tissue Inhibitors of Metalloproteinases). An imbalance between MMPs and TIMPs is linked to arthritis and cancer metastasis. * **Cancer:** Overexpression of MMP-2 and MMP-9 (Gelatinases) is a high-yield marker for high metastatic potential in tumors. * **Scurvy Connection:** MMPs are involved in the turnover of collagen; lack of Vitamin C affects collagen synthesis, but MMPs continue to degrade existing matrix, leading to weak connective tissue.

Q: Non-competitive enzyme inhibition leads to what change in Vmax and Km?

Vmax is unchanged, Km increases. **Explanation:** In **Competitive Inhibition**, the inhibitor structurally resembles the substrate and competes for the same **active site** on the enzyme. 1. **Km Increases:** Because the inhibitor competes with the substrate, a higher concentration of substrate is required to displace the inhibitor and reach half-maximal velocity ($V_{max}/2$). This reflects a **decreased affinity** of the enzyme for the substrate. 2. **Vmax is Unchanged:** If the substrate concentration is increased to sufficiently high levels, it will eventually outcompete all inhibitor molecules. Therefore, the enzyme can still reach its original maximum velocity ($V_{max}$). **Analysis of Options:** * **Option B (Correct):** Accurately describes competitive inhibition where $V_{max}$ remains constant but $K_m$ increases. * **Option A:** Describes **Non-competitive inhibition**, where the inhibitor binds to an allosteric site, reducing the overall enzyme concentration (decreasing $V_{max}$) without affecting the substrate's ability to bind ($K_m$ unchanged). * **Option C:** This pattern is not typically seen in standard inhibition models. * **Option D:** Describes **Mixed inhibition**, where both the $V_{max}$ and $K_m$ are affected. **High-Yield NEET-PG Pearls:** * **Lineweaver-Burk Plot:** In competitive inhibition, the lines intersect at the **Y-axis** ($1/V_{max}$ is the same). * **Classic Example:** **Statins** (HMG-CoA Reductase inhibitors) and **Methotrexate** (Dihydrofolate Reductase inhibitor) are classic competitive inhibitors. * **Mnemonic:** **C**ompetitive = **C**onstant $V_{max}$, but $K_m$ goes **U**p (**CU**).

Q: Which of the following enzymes requires NAD as a cofactor?

alpha-Ketoglutarate dehydrogenase. **Explanation:** The **$\alpha$-Ketoglutarate Dehydrogenase (α-KGDH) complex** is a key regulatory enzyme in the Citric Acid Cycle (TCA cycle). It catalyzes the oxidative decarboxylation of $\alpha$-ketoglutarate to succinyl-CoA. This enzyme is a multi-enzyme complex that requires **five essential cofactors**: Thiamine pyrophosphate (TPP/B1), Lipoic acid, CoA (B5), FAD (B2), and **NAD+ (B3)**. NAD+ acts as the final electron acceptor in this reaction, being reduced to NADH. **Analysis of Options:** * **Isocitrate Dehydrogenase (Option B):** While this enzyme also produces NADH in the TCA cycle, the question specifically highlights $\alpha$-KGDH as the classic "multi-enzyme complex" similar to Pyruvate Dehydrogenase. Note: In many contexts, Isocitrate Dehydrogenase is also NAD-dependent; however, $\alpha$-KGDH is the high-yield answer often tested for its specific requirement of the "five-cofactor" group. * **Citrate Synthase (Option A):** This is a condensation reaction (Acetyl-CoA + Oxaloacetate → Citrate). It does not involve redox chemistry and thus does not require NAD. * **Succinate Thiokinase (Option D):** Also known as Succinyl-CoA synthetase, this enzyme performs substrate-level phosphorylation to produce **GTP** (or ATP). It does not require NAD. **High-Yield Clinical Pearls for NEET-PG:** * **The "Tender Loving Care For Nancy" Mnemonic:** Use this to remember the five cofactors for both $\alpha$-KGDH and Pyruvate Dehydrogenase: **T**PP, **L**ipoic acid, **C**oA, **F**AD, **N**AD. * **Arsenite Poisoning:** Arsenite inhibits enzymes requiring Lipoic acid (like $\alpha$-KGDH), leading to a buildup of upstream metabolites and lactic acidosis. * **Rate-Limiting Step:** While Isocitrate Dehydrogenase is the primary rate-limiting step of the TCA cycle, $\alpha$-KGDH is a major site of inhibition by high ATP, NADH, and Succinyl-CoA.

Q: Glycogen phosphorylase is classified as which type of enzyme?

Transferase. **Explanation:** **Why Transferase is correct:** Glycogen phosphorylase is the rate-limiting enzyme of glycogenolysis. It catalyzes the breakdown of glycogen by adding an inorganic phosphate ($P_i$) to the terminal $\alpha$-1,4-glycosidic bond. This process is called **phosphorolysis**, resulting in the release of Glucose-1-Phosphate. According to the IUBMB classification, enzymes that transfer a functional group (in this case, a phosphate group) from one substrate to another are classified as **Transferases (EC 2)**. Specifically, glycogen phosphorylase is a glycosyltransferase. **Why other options are incorrect:** * **Oxidoreductases (EC 1):** These catalyze oxidation-reduction reactions (e.g., LDH). Glycogen phosphorylase does not involve the transfer of electrons or hydrogen. * **Hydrolases (EC 3):** These break bonds by adding water (hydrolysis). While glycogen phosphorylase breaks a bond, it uses phosphate instead of water. If it were a hydrolase, it would release free glucose (like the debranching enzyme's $\alpha$-1,6-glucosidase activity). * **Lyases (EC 4):** These catalyze the cleavage of bonds by means other than hydrolysis or oxidation, often forming a double bond or adding groups to double bonds (e.g., Aldolase). **High-Yield Clinical Pearls for NEET-PG:** 1. **Co-enzyme:** Glycogen phosphorylase requires **Pyridoxal Phosphate (PLP/Vitamin B6)** as an essential cofactor. 2. **Regulation:** It is activated by phosphorylation (via Phosphorylase Kinase) and allosterically activated by **AMP** in the muscle. 3. **Clinical Correlation:** A deficiency of liver glycogen phosphorylase leads to **Hers Disease (GSD Type VI)**, characterized by hepatomegaly and mild hypoglycemia. 4. **Key Distinction:** Do not confuse "Phosphorylase" (Transferase) with "Phosphatase" (Hydrolase).

Question 1

All of the following are true about Xanthine oxidase, EXCEPT:

Accepted Answer

Produces H2O

Answer

Contains iron

Answer

Contains molybdenum

Answer

Flavoprotein

Question 2

Selenium is a cofactor for which of the following enzymes?

Accepted Answer

Glutathione peroxidase

Answer

Glutathione reductase

Answer

Glutathione synthetase

Answer

Glutathione dehydrogenase

Question 3

ATP synthetase is a marker of which cellular organelle?

Accepted Answer

Mitochondria

Answer

Golgi apparatus

Answer

Cytosol

Answer

Endoplasmic reticulum

Question 4

Hyperamylasemia is seen in all of the following conditions except:

Accepted Answer

Cystic fibrosis

Answer

Pancreatic pseudocyst

Answer

Macroamylasemia

Answer

Parotitis

Question 5

Which of the following cell organelles is rich in catalases?

Accepted Answer

Peroxisome

Answer

Mitochondria

Answer

Ribosome

Answer

Cell membrane

Question 6

Alkaline phosphatase is found in all organs, except:

Accepted Answer

Heart

Answer

Bone

Answer

Placenta

Answer

Lungs

Question 7

What are Matrix metalloproteinases?

Accepted Answer

Cathepsins

Answer

Zinc metalloproteinases

Answer

Copper metalloproteinases

Answer

Cadmium metalloproteinases

Question 8

Non-competitive enzyme inhibition leads to what change in Vmax and Km?

Accepted Answer

Vmax is unchanged, Km increases

Answer

Vmax decreases, Km is unchanged

Answer

Vmax is unchanged, Km decreases

Answer

Vmax decreases, Km increases

Question 9

Which of the following enzymes requires NAD as a cofactor?

Accepted Answer

alpha-Ketoglutarate dehydrogenase

Answer

Citrate Synthase

Answer

Isocitrate Dehydrogenase

Answer

Succinate Thiokinase

Question 10

Glycogen phosphorylase is classified as which type of enzyme?

Accepted Answer

Transferase

Answer

Oxidoreductase

Answer

Hydrolase

Answer

Lyase

Enzymes — MCQs

Enzymes — MCQs

On this page

Practice by Chapter

Want unlimited practice?